These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28298171)
21. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets. Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958 [TBL] [Abstract][Full Text] [Related]
22. Film-coated matrix mini-tablets for the extended release of a water-soluble drug. Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797 [TBL] [Abstract][Full Text] [Related]
23. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture. Van Nguyen H; Nguyen VH; Lee BJ Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034 [TBL] [Abstract][Full Text] [Related]
24. Understanding and managing the impact of HPMC variability on drug release from controlled release formulations. Zhou D; Law D; Reynolds J; Davis L; Smith C; Torres JL; Dave V; Gopinathan N; Hernandez DT; Springman MK; Zhou CC J Pharm Sci; 2014 Jun; 103(6):1664-72. PubMed ID: 24652662 [TBL] [Abstract][Full Text] [Related]
25. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. Varshosaz J; Tavakoli N; Kheirolahi F AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155 [TBL] [Abstract][Full Text] [Related]
26. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release. Hiremath PS; Saha RN Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928 [TBL] [Abstract][Full Text] [Related]
27. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet. Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912 [TBL] [Abstract][Full Text] [Related]
28. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile. Newton AM; Lakshmanan P Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626 [TBL] [Abstract][Full Text] [Related]
29. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
30. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998 [TBL] [Abstract][Full Text] [Related]
31. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets. Ali R; Dashevsky A; Bodmeier R Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241 [TBL] [Abstract][Full Text] [Related]
32. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis. Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866 [TBL] [Abstract][Full Text] [Related]
33. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets. Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563 [TBL] [Abstract][Full Text] [Related]
34. A novel approach in distinguishing between role of hydrodynamics and mechanical stresses similar to contraction forces of GI tract on drug release from modified release dosage forms. Takieddin M; Fassihi R AAPS PharmSciTech; 2015 Apr; 16(2):278-83. PubMed ID: 25273030 [TBL] [Abstract][Full Text] [Related]
35. Effect of hydrophobic inclusions on polymer swelling kinetics studied by magnetic resonance imaging. Gajdošová M; Pěček D; Sarvašová N; Grof Z; Štěpánek F Int J Pharm; 2016 Mar; 500(1-2):136-43. PubMed ID: 26780121 [TBL] [Abstract][Full Text] [Related]
36. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine. Nie S; Pan W; Li X; Wu X Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336 [TBL] [Abstract][Full Text] [Related]
37. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends. Hamed R; AlJanabi R; Sunoqrot S; Abbas A Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145 [TBL] [Abstract][Full Text] [Related]
38. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. Ju RT; Nixon PR; Patel MV J Pharm Sci; 1995 Dec; 84(12):1455-63. PubMed ID: 8748329 [TBL] [Abstract][Full Text] [Related]
39. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC. Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437 [TBL] [Abstract][Full Text] [Related]
40. Reducing Burst Release Effect of Freely Water-Soluble Drug Incorporated into Gastro-Floating Formulation Below HPMC Threshold Concentration Through Interpolymer Complex. Choiri S; Sulaiman TNS; Rohman A AAPS PharmSciTech; 2019 May; 20(5):196. PubMed ID: 31123934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]